Skip to content
OpenCapital
Get started

Halozyme Therapeutics HALO EBIT

EBIT at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
——
BridgeBio Pharma logo
BridgeBio PharmaBBIO
——
Arrowhead Research logo
Arrowhead ResearchARWR
——
AptarGroup logo
AptarGroupATR
——
AbbVie logo
AbbVieABBV
——
Alkermes logo
AlkermesALKS
——

Other financials

Income statement

See full
Revenue$376.7M+42.2%
Gross profit$297.5M+37.4%
Operating income$184.5M+30.4%
Net income$150.0M+27.1%
EPS (diluted)$1.22+31.2%

Balance sheet

See full
Cash & equivalents$312.0M+76.9%
Total debt$2.2B+41.7%
Total equity$219.6M-54.5%
Total assets$2.7B+21.7%

Cash flow

See full
Operating cash flow$180.1M+16.8%
CapEx$3.7M+294%
Free cash flow$176.3M+15.0%

Valuation

See full
Market cap$8.13B-2.9%
Enterprise value$10B+3.0%
P/E13.4×-3.8×
P/S5.4×-2.3×

Profitability

See full
Gross margin82.8%-0.7pp
Operating margin59.3%+9.0pp
Net margin47.9%+6.5pp
FCF margin44.3%-1.5pp

Returns & leverage

See full
Return on equity124.5%+12.7pp
Debt / equity9.9×+6.7×
Current ratio2.8×-5.6×

Where this comes from

Calculated from Halozyme Therapeutics’s reported figures.

$184.5Moperating income+$180.3Mincome before tax+$5.5Minterest expense=$184.52M

The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Halozyme Therapeutics's EBIT?
Halozyme Therapeutics (HALO) reported EBIT of $184.52M in Q1 2026.
How has Halozyme Therapeutics's EBIT changed year-over-year?
Halozyme Therapeutics's EBIT increased by 30.4% year-over-year, from $141.54M to $184.52M.
What is the long-term trend for Halozyme Therapeutics's EBIT?
Over 3 years (2021 to 2024), Halozyme Therapeutics's EBIT has grown at a 26.0% compound annual growth rate (CAGR), from $275.9M to $551.48M.
What does EBIT mean?
Profit before interest and taxes — the business's core earning power.
How do you interpret EBIT?
Higher is better. Because it adds back interest, EBIT compares earning power across firms with very different debt loads — the base for interest coverage and the EV/EBIT multiple. For filers reporting operating income it equals that line, excluding non-operating swings.
How does EBIT compare across companies?
Comparable across companies regardless of leverage or tax domicile; the standard 'earning power' line for cross-company analysis. Least meaningful for banks and insurers.